IL6 and Thrombocytopenia: The immune dysregulation in ITP not only causes thrombocytopenia but also triggers a persistent low-grade systemic inflammatory response through the activation of pro-inflammatory cytokine networks, such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) (1, 6).